India Glycols Ltd Quality Grade Upgrade Reflects Improved Business Fundamentals

Quality Grade Upgrade and Its Implications

On 10 February 2026, India Glycols Ltd’s quality grade was upgraded from Sell to Hold, accompanied by a rise in its quality rating from below average to average. This change reflects a reassessment of the company’s financial health and operational performance, signalling to investors that the firm’s fundamentals have stabilised and improved relative to its past standing.

The company’s current Mojo Score stands at 64.0, a moderate rating that supports the Hold recommendation. While not yet in the ‘Good’ or ‘Strong Buy’ territory, this upgrade indicates a positive trajectory in key financial parameters that investors should consider.

Profitability and Growth Metrics Show Encouraging Trends

India Glycols has demonstrated robust growth in earnings before interest and tax (EBIT), with a five-year compound annual growth rate (CAGR) of 21.55%. This outpaces its sales growth over the same period, which stands at a healthy 9.85% CAGR. The disparity between EBIT and sales growth suggests improving operational leverage and margin expansion, a favourable sign for profitability.

Return on capital employed (ROCE) averages 8.33%, while return on equity (ROE) is at 9.08%. Although these returns are modest compared to some peers in the commodity chemicals sector, they represent an improvement from previous years and contribute to the upgraded quality assessment. The company’s tax ratio of 22.12% aligns with industry norms, indicating stable tax management.

Debt Levels and Interest Coverage Reflect Improved Financial Stability

Debt metrics have also shown signs of improvement. The average debt to EBITDA ratio is 3.59, which, while still on the higher side, is manageable given the company’s interest coverage ratio of 2.42 times. This coverage ratio indicates that India Glycols generates sufficient EBIT to comfortably service its interest obligations, reducing financial risk.

Net debt to equity averages 0.61, signalling a moderate leverage position. The absence of pledged shares (0.00%) further enhances the company’s creditworthiness and investor confidence, as it implies no encumbrances on promoter holdings.

Capital Efficiency and Dividend Policy

Sales to capital employed ratio stands at 0.95, suggesting that the company is generating nearly ₹0.95 in sales for every ₹1 of capital employed. This level of capital turnover is reasonable within the commodity chemicals industry, though there remains scope for improvement to match higher-performing peers.

India Glycols maintains a conservative dividend payout ratio of 13.41%, reflecting a balanced approach between rewarding shareholders and retaining earnings for reinvestment. This payout policy supports sustainable growth while providing some income to investors.

Comparative Industry Positioning

Within the commodity chemicals sector, India Glycols now holds an average quality rating, placing it alongside companies such as Atul and Aarti Industries, which also share average grades. However, it trails behind peers like Navin Fluorine International, Himadri Speciality Chemical, and Deepak Nitrite, all rated as ‘Good’ in quality.

This relative positioning highlights that while India Glycols has made commendable progress, there remains room for further enhancement in operational efficiency and financial metrics to reach the upper echelons of the sector.

Stock Performance and Market Context

India Glycols’ stock price currently trades at ₹968.40, down 2.30% on the day, with a 52-week high of ₹1,222.85 and a low of ₹502.50. Despite recent volatility, the stock has delivered impressive long-term returns, outperforming the Sensex significantly. Over the past five years, the stock has returned 337.94%, compared to the Sensex’s 63.46%, and over ten years, the stock’s return of 2,478.96% dwarfs the Sensex’s 267.00%.

Shorter-term returns are more mixed, with a 1-year gain of 59.63% outperforming the Sensex’s 10.41%, but a year-to-date decline of 4.96% versus the Sensex’s 1.16% fall. This volatility reflects sector-specific challenges and broader market dynamics.

Outlook and Investor Considerations

The upgrade in India Glycols’ quality grade to average and the Hold rating suggest that the company is on a stabilising path with improving fundamentals. Investors should note the company’s solid EBIT growth, manageable debt levels, and improving returns, which collectively support a more positive outlook than before.

However, the company’s ROCE and ROE remain modest relative to top-tier peers, and its leverage, while controlled, is still a factor to monitor. The conservative dividend payout also indicates a cautious capital allocation strategy, which may appeal to investors favouring stability over aggressive growth.

Conclusion

India Glycols Ltd’s recent quality grade upgrade from below average to average reflects meaningful improvements in its business fundamentals, including stronger EBIT growth, better interest coverage, and a more balanced debt profile. While the company still faces challenges in elevating its returns to peer-leading levels, the current trajectory supports a Hold rating and a more optimistic outlook for investors seeking exposure to the commodity chemicals sector.

Long-term investors may find value in the company’s demonstrated ability to outperform the broader market over extended periods, though they should remain vigilant regarding leverage and capital efficiency metrics as the company continues its growth journey.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →